Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | BID | P55957 | 3/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.37 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.37 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.37 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.37 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.37 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817803 | 0.92 | LIPG (0.49) | LIPGALOX5PTGS2BIDMCL1 | |
| SCHEMBL11333647 | 0.92 | LIPG (0.49) | LIPGALOX5PTGS2BIDMCL1 | |
| SCHEMBL10354084 | 0.92 | LIPG (0.49) | LIPGALOX5PTGS2BIDMCL1 | |
| SCHEMBL819273 | 0.85 | LIPG (0.45) | LIPGALOX5PTGS2BIDMCL1 | |
| SCHEMBL4857184 | 0.84 | GABRA1 (0.40) | LIPGALOX5PTGS2CYP3A4CYP2D6 | |
| SCHEMBL818006 | 0.83 | KDM4E (0.35) | ALOX5PTGS2HPGD | |
| Ammonia Solution, Strong SCHEMBL9810933 | 0.83 | LIPG (0.44) | LIPGALOX5PTGS2BIDMCL1 | |
| Water SCHEMBL27341058 | 0.83 | LIPG (0.44) | LIPGALOX5PTGS2BIDMCL1 | |
| SCHEMBL816916 | 0.82 | TYR (0.41) | LIPGALOX5CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL392416 | 0.81 | LIPG (0.47) | LIPGALOX5PTGS2BIDMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| US-11723888-B2 | Polymer conjugated thyrointegrin antagonists | NANOPHARMACEUTICALS LLC (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230181501-A1 | POLYMER CONJUGATED THYROINTEGRIN ANTAGONISTS | NANOPHARMACEUTICALS LLC | 2023-06-15 | — | — | US | disclosed |
| WO-2023107412-A1 | POLYMER CONJUGATED THYROINTEGRIN ANTAGONISTS | NANOPHARMACEUTICALS LLC (US) | 2023-06-15 | — | — | WO | disclosed |
| CN-110183603-B | Phosphorus-containing release agent, optical polymerizable composition containing same, and method for producing same | SKC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| EP-4142798-A1 | COMPOSITION OF SCALABLE THYROINTEGRIN ANTAGONISTS WITH IMPROVED BLOOD BRAIN BARRIER PENETRATION AND RETENTION IN BRAIN TUMORS | NanoPharmaceuticals LLC (US) | 2023-03-08 | — | — | EP | disclosed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| EP-0017623-A2 | Hardenable mixtures containing dimethylamino derivatives | CIBA-GEIGY AG (CH) | 1980-10-15 | — | — | EP | disclosed |
| EP-0016722-A1 | Stabilised flame-resistant plastics moulding composition and process for stabilising plastics made flame-resistant with organic bromine compounds | CIBA-GEIGY AG (CH) | 1980-10-01 | — | — | EP | disclosed |
| US-4133830-A | RECYCLING BY-PRODUCTS TO SUCCESSIVE RUNS TO IMPROVE YIELD | STAUFFER CHEMICAL COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4130583-A | AUTOGENOUS PRESSURE | STAUFFER CHEMICAL COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4112024-A | PESTICIDES | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-09-05 | — | — | US | disclosed |
| US-4003939-A | PESTICIDES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723888-B2 | Polymer conjugated thyrointegrin antagonists | TEK, HDGF, PTGFR | LIPG 666/4885ALOX5 2497/4885PTGS2 889/4885 |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | LIPG 2752/4885ALOX5 188/4885PTGS2 3242/4885 |
| US-20230181501-A1 | POLYMER CONJUGATED THYROINTEGRIN ANTAGONISTS | TEK, HDGF, PTGFR | LIPG 666/4885ALOX5 2497/4885PTGS2 889/4885 |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | LIPG 1449/4885ALOX5 539/4885PTGS2 3246/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | LIPG 1449/4885ALOX5 539/4885PTGS2 3246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.